Search Within

Catherine H Van Poznak

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (2)
  2. Meeting Abstract (2)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (4)
  2. Biostatistics Service (4)
  3. Breast Medicine Service (4)
  4. Department of Medicine (4)
  5. Department of Pathology and Laboratory Medicine (4)
  6. Epidemiology and Biostatistics (4)

More Groups

People
  1. Andrew Seidman (4)
  2. Clifford Hudis (4)
  3. Katherine Panageas (4)
  4. Larry Norton (4)
  5. Lee Tan (4)
  6. Chaya Moskowitz (2)

More People

Years
  1. 2005 (1)
  2. 2003 (1)
  3. 2002 (1)
  4. 2000 (1)
Publications
  1. Breast Cancer Research and Treatment (1)
  2. Cancer Investigation (1)
  3. Journal of Clinical Oncology (1)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (1)
Publishers
  1. American Association for Cancer Research (1)
  2. American Society of Clinical Oncology (1)
  3. Informa Healthcare (1)
  4. Springer (1)

Results (4)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phosphorylated/activated HER2 as a marker of clinical resistance to single agent taxane chemotherapy for metastatic breast cancer
    Journal Article

    Modi, S.; DiGiovanna, M. P.; Lu, Z.; Moskowitz, C.; Panageas, K. S.; Van Poznak, C.; Hudis, C. A.; Norton, L.; Tan, L.; Stern, D. F.; more...
    Cancer Investigation (2005)

    Fulltext@MSK | Save
  • Phosphorylated/activated HER2 (P-HER2) as a marker of clinical resistance to single agent taxane chemotherapy for meta-static breast cancer (MBC)
    Meeting Abstract

    Modi, S.; DiGiovanna, M. P.; Lu, Z.; Moskowitz, C.; Panageas, K. S.; Van Poznak, C.; Hudis, C. A.; Norton, L.; Tan, L.; Stern, D. F.; more...
    Proceedings of the American Association for Cancer Research Annual Meeting (2003)

    Fulltext@MSK | Save
  • Assessment of molecular markers of clinical sensitivity to single-agent taxane therapy for metastatic breast cancer
    Journal Article

    Van Poznak, C.; Tan, L.; Panageas, K. S.; Arroyo, C. D.; Hudis, C.; Norton, L.; Seidman, A. D.
    Journal of Clinical Oncology (2002)

    Fulltext@MSK | Save
  • Clinical-pathologic assessment of the clinical sensitivity to single agent taxane (T) therapy for metastatic breast cancer (MBC)
    Meeting Abstract

    Van Poznak, C.; Tan, L.; Panageas, K.; Arroyo, C.; Hudis, C.; Norton, L.; Seidman, A. D.
    Breast Cancer Research and Treatment (2000)

    Fulltext@MSK | Save